• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Taysha Gene Therapies, Inc. - Common Stock (NQ:TSHA)

5.140 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Jan 8, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 5.140
Bid (Size) 5.200 (300)
Ask (Size) 5.210 (100)
Prev. Close 5.140
Today's Range 5.140 - 5.140
52wk Range 1.050 - 6.020
Shares Outstanding 64,465,037
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Taysha Gene Therapies Inc (NASDAQ:TSHA) Stock Slumps on Q3 Revenue Miss Despite Key Regulatory Win for TSHA-102 ↗
November 04, 2025
Taysha Gene Therapies stock fell after Q3 results, with a revenue miss overshadowing positive FDA Breakthrough Therapy designation for its Rett syndrome drug. 
Via Chartmill
News headline image
Earnings Scheduled For November 4, 2025 ↗
November 04, 2025
 
Via Benzinga

Performance

YTD
-2.1%
-2.1%
1 Month
-3.2%
-3.2%
3 Month
+2.8%
+2.8%
6 Month
+101.6%
+101.6%
1 Year
+166.3%
+166.3%

More News

Read More
News headline image
Olema Pharmaceuticals, Exelixis, Genmab And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗
October 20, 2025
Via Benzinga
News headline image
Why Is Taysha Gene Therapies Stock Falling Friday? ↗
October 17, 2025
Via Benzinga
News headline image
Taysha Gene Therapies Stock Soars To 3-Year High After FDA Boost — Wall Street Calls Rett Drug ‘Derisked’ And Ahead Of Rivals ↗
October 03, 2025
Via Stocktwits
News headline image
What's Next: Taysha Gene Therapies's Earnings Preview ↗
August 11, 2025
Via Benzinga
News headline image
Where Taysha Gene Therapies Stands With Analysts ↗
June 02, 2025
Via Benzinga
News headline image
Healthcare Sector Shines Amidst Market Turbulence, Bolstering S&P 500 Resilience
October 02, 2025
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
News headline image
Demystifying Taysha Gene Therapies: Insights From 6 Analyst Reviews ↗
October 02, 2025
Via Benzinga
News headline image
Discover the most active stocks in Thursday's session. ↗
October 02, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
October 02, 2025
Via Benzinga
News headline image
Here are the top movers in Thursday's session. ↗
October 02, 2025
Via Chartmill
News headline image
Taysha Gene Therapies, Canaan, Ondas Holdings And Other Big Stocks Moving Higher On Thursday ↗
October 02, 2025
Via Benzinga
Topics Stocks
News headline image
Taysha Gene Therapies Stock Soars After FDA Grants Breakthrough Therapy Designation To Gene Therapy ↗
October 02, 2025
Via Stocktwits
News headline image
Which stocks are gapping on Thursday? ↗
October 02, 2025
Via Chartmill
News headline image
Top 2 Health Care Stocks That May Keep You Up At Night This Month ↗
October 02, 2025
Via Benzinga
News headline image
What's Driving the Market Sentiment Around Taysha Gene Therapies? ↗
September 18, 2025
Via Benzinga
News headline image
Is Taysha Gene Therapies Gaining or Losing Market Support? ↗
August 25, 2025
Via Benzinga
News headline image
A Glimpse Into The Expert Outlook On Taysha Gene Therapies Through 11 Analysts ↗
August 13, 2025
Via Benzinga
News headline image
Beyond The Numbers: 10 Analysts Discuss Taysha Gene Therapies Stock ↗
July 01, 2025
Via Benzinga
News headline image
Retail Buzz Surges Around Taysha Gene Therapies After Positive Rett Syndrome Trial Data ↗
June 03, 2025
Via Stocktwits
News headline image
Why Is Taysha Gene Therapies Stock Trading Higher On Thursday? ↗
May 29, 2025
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
May 29, 2025
Via Benzinga
News headline image
Earnings Scheduled For August 12, 2025 ↗
August 12, 2025
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
May 28, 2025
Via Benzinga

Frequently Asked Questions

Is Taysha Gene Therapies, Inc. - Common Stock publicly traded?
Yes, Taysha Gene Therapies, Inc. - Common Stock is publicly traded.
What exchange does Taysha Gene Therapies, Inc. - Common Stock trade on?
Taysha Gene Therapies, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Taysha Gene Therapies, Inc. - Common Stock?
The ticker symbol for Taysha Gene Therapies, Inc. - Common Stock is TSHA on the Nasdaq Stock Market
What is the current price of Taysha Gene Therapies, Inc. - Common Stock?
The current price of Taysha Gene Therapies, Inc. - Common Stock is 5.140
When was Taysha Gene Therapies, Inc. - Common Stock last traded?
The last trade of Taysha Gene Therapies, Inc. - Common Stock was at 01/08/26 04:00 PM ET
What is the market capitalization of Taysha Gene Therapies, Inc. - Common Stock?
The market capitalization of Taysha Gene Therapies, Inc. - Common Stock is 331.35M
How many shares of Taysha Gene Therapies, Inc. - Common Stock are outstanding?
Taysha Gene Therapies, Inc. - Common Stock has 331M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap